Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 409

1.

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004.

Mooney JD, Weir A, McMenamin J, Ritchie LD, Macfarlane TV, Simpson CR, Ahmed S, Robertson C, Clarke SC.

BMC Infect Dis. 2008 Apr 23;8:53. doi: 10.1186/1471-2334-8-53.

PMID:
18433473
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.

Andrews RM, Counahan ML, Hogg GG, McIntyre PB.

Vaccine. 2004 Nov 25;23(2):132-8.

PMID:
15531029
[PubMed - indexed for MEDLINE]
3.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
[PubMed - indexed for MEDLINE]
Free Article
4.

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.

Vestrheim DF, Løvoll O, Aaberge IS, Caugant DA, Høiby EA, Bakke H, Bergsaker MR.

Vaccine. 2008 Jun 19;26(26):3277-81. doi: 10.1016/j.vaccine.2008.03.087. Epub 2008 Apr 18.

PMID:
18456376
[PubMed - indexed for MEDLINE]
5.

Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2005 Sep 16;54(36):893-7.

PMID:
16163262
[PubMed - indexed for MEDLINE]
Free Article
6.

Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults.

Singleton RJ, Butler JC, Bulkow LR, Hurlburt D, O'Brien KL, Doan W, Parkinson AJ, Hennessy TW.

Vaccine. 2007 Mar 8;25(12):2288-95. Epub 2006 Dec 11.

PMID:
17254673
[PubMed - indexed for MEDLINE]
7.

The epidemiology of invasive pneumococcal disease in children in Far North Queensland.

Fagan RL, Hanna JN, Messer RD, Brookes DL, Murphy DM.

J Paediatr Child Health. 2001 Dec;37(6):571-5.

PMID:
11903838
[PubMed - indexed for MEDLINE]
8.

Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal polysaccharide vaccine program in Indigenous adults in the Northern Territory of Australia.

Moberley S, Krause V, Cook H, Mulholland K, Carapetis J, Torzillo P, Andrews R.

Vaccine. 2010 Mar 8;28(11):2296-301. doi: 10.1016/j.vaccine.2009.12.066. Epub 2010 Jan 28.

PMID:
20116468
[PubMed - indexed for MEDLINE]
9.

Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults.

Shafinoori S, Ginocchio CC, Greenberg AJ, Yeoman E, Cheddie M, Rubin LG.

Pediatr Infect Dis J. 2005 Jan;24(1):10-6.

PMID:
15665704
[PubMed - indexed for MEDLINE]
10.

Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8.

PMID:
18272956
[PubMed - indexed for MEDLINE]
Free Article
11.

Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008-2011.

Gutierrez Rodriguez MA, Ordobas Gavin MA, Garcia-Comas L, Sanz Moreno JC, Cordoba Deorador E, Lasheras Carbajo MD, Taveira Jimenez JA, Martin Martinez F, Iniesta Fornies D, Arce Arnaez A.

Euro Surveill. 2014 Oct 9;19(40):20922.

PMID:
25323079
[PubMed - indexed for MEDLINE]
Free Article
12.

Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period.

De Serres G, Pilishvili T, Link-Gelles R, Reingold A, Gershman K, Petit S, Farley MM, Harrison LH, Lynfield R, Bennett NM, Baumbach J, Thomas A, Schaffner W, Beall B, Whitney C, Moore M.

Vaccine. 2012 Jun 8;30(27):4067-72. doi: 10.1016/j.vaccine.2012.04.017. Epub 2012 Apr 21.

PMID:
22525797
[PubMed - indexed for MEDLINE]
13.

Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010.

Thoon KC, Chong CY, Tee NW.

Int J Infect Dis. 2012 Mar;16(3):e209-15. doi: 10.1016/j.ijid.2011.11.014. Epub 2012 Jan 26.

PMID:
22281191
[PubMed - indexed for MEDLINE]
Free Article
14.

Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009.

Hanna JN, Humphreys JL, Murphy DM, Smith HV.

Med J Aust. 2010 Oct 4;193(7):392-6.

PMID:
20919968
[PubMed - indexed for MEDLINE]
15.

[Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].

Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.

Enferm Infecc Microbiol Clin. 2009 Jan;27(1):14-21. doi: 10.1016/j.eimc.2008.03.001. Epub 2009 Jan 9. Spanish.

PMID:
19217998
[PubMed - indexed for MEDLINE]
16.

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme.

Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Andersen PH, Howitz M, Krogfelt KA, Lambertsen L, Konradsen HB.

Vaccine. 2010 Mar 19;28(14):2642-7. doi: 10.1016/j.vaccine.2010.01.017. Epub 2010 Jan 20.

PMID:
20096392
[PubMed - indexed for MEDLINE]
17.

Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom.

Parsons HK, Metcalf SC, Tomlin K, Read RC, Dockrell DH.

J Infect. 2007 May;54(5):435-8. Epub 2006 Oct 17.

PMID:
17052760
[PubMed - indexed for MEDLINE]
18.

Invasive pneumococcal disease among White Mountain Apache adults, 1991-2005.

Bliss SJ, Larzalere-Hinton F, Lacapa R, Eagle KR, Frizzell F, Parkinson A, Reid R, Craig M, Santosham M, O'Brien KL.

Arch Intern Med. 2008 Apr 14;168(7):749-55. doi: 10.1001/archinte.168.7.749.

PMID:
18413558
[PubMed - indexed for MEDLINE]
19.

Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.

Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C; EVAN Study Group.

Clin Infect Dis. 2006 Oct 1;43(7):860-8. Epub 2006 Aug 21.

PMID:
16941367
[PubMed - indexed for MEDLINE]
Free Article
20.

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.

Rückinger S, van der Linden M, Reinert RR, von Kries R, Burckhardt F, Siedler A.

Vaccine. 2009 Jun 24;27(31):4136-41. doi: 10.1016/j.vaccine.2009.04.057. Epub 2009 May 9.

PMID:
19406190
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk